Pure Global

SARS-CoV-2 IgM/IgG Antibody Assay Kit (SARS-CoV-2 IgM/IgG Antibody Assay Kit ) - India CDSCO Medical Device Registration

SARS-CoV-2 IgM/IgG Antibody Assay Kit (SARS-CoV-2 IgM/IgG Antibody Assay Kit ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000383_cc2c1703bdb8a4a13f0d2a482d112faf_1a1a703e09daedd82c1bf8482875d14e. This device is marketed under the brand name Immunofluorescence. The license holder is BIODX HEALTHCARE, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
SARS-CoV-2 IgM/IgG Antibody Assay Kit (SARS-CoV-2 IgM/IgG Antibody Assay Kit )
UID: IMP/IVD/2020/000383_cc2c1703bdb8a4a13f0d2a482d112faf_1a1a703e09daedd82c1bf8482875d14e

Brand Name

Immunofluorescence

License Holder

BIODX HEALTHCARE

Device Class

Class C

Approving Authority

CDSCO

Product Information

This kit is used for the qualitative detection of specific IgM antibodies and IgG antibodies against novel coronavirus (Immunofluorescence) in human specimens (Immunofluorescence)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing